The Filing Desk

Ginkgo Bioworks vs Personalis

Ginkgo Bioworks DNA · Personalis PSNL · Life Sciences Tools & Services

Ginkgo Bioworks reported revenue of $170 million in fiscal 2025, 2.4 times Personalis' $70 million in fiscal 2025. Ginkgo Bioworks' revenue fell 25.1% in its latest year, and Personalis' fell 17.7%. Ginkgo Bioworks had an operating margin of -185.3%, against -126.4% at Personalis. Free cash flow was −$179 million at Ginkgo Bioworks and −$79 million at Personalis.

Side by side

Ginkgo BioworksPersonalis
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$170M$70M
Revenue growth−25.1%−17.7%
Revenue growth a year, last 5 years17.3%−2.4%
Gross margin—22.6%
Operating margin−185.3%−126.4%
Net margin−183.8%−116.7%
Free cash flow−$179M−$79M
Free cash flow margin−105.0%−114.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count6.9%50.6%
Last close$9.61$15.71
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Ginkgo BioworksPersonalis
Operating margin
Percent of revenue
Ginkgo BioworksPersonalis
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Ginkgo BioworksPersonalis

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ginkgo Bioworks and Personalis pages.